Eli Lilly And Co (NYSE:LLY) and Novo Nordisk (NYSE:NVO), are reportedly being sued in Texas by compounding pharmacy Strive ...

Eli Lilly (LLY) downgraded to Sell as obesity-drug competition and pricing pressure rise; stretched valuation boosts downside ...

The rising popularity of weight loss drugs is a key reason healthcare company Eli Lilly (NYSE: LLY) has been soaring in value ...

Nvidia and Eli Lilly's AI tie-up shows drug discovery emerging as a new ETF growth theme across semiconductors and health ...

Powell suggested a DOJ subpoena and threats of criminal indictment are a pretext aimed at getting the Fed to cut rates.

NVIDIA’s market is heating up, approaching the boiling point once again, as its long-term outlook swells and the valuation ...

Nvidia stock traded largely flat on Monday, showing little reaction to news of a major new partnership with Eli Lilly.

Wall St. provides estimates for future stock prices of Eli Lilly from 2026 to 2030 based on projected revenue and net income.

Eli Lilly stock prepares €15B Abivax acquisition as tirzepatide revenue hits $24.8B. Orforglipron oral weight loss drug ...

Eli Lilly is riding the wave of a booming weight management market. Eli Lilly's tirzepatide, sold under the brand names ...

Eli Lilly and Company and Ventyx Biosciences, Inc., a San Diego-based clinical-stage biopharmaceutical company focused on ...

The terms of the agreement entail that Eli Lilly and Company (NYSE:LLY) would acquire all the outstanding shares of Ventyx ...